{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:42:12Z","timestamp":1772329332143,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFC0900600\/2016YFC0900603"],"award-info":[{"award-number":["2016YFC0900600\/2016YFC0900603"]}]},{"name":"Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is a well-documented empirical relationship between lipoprotein (a) [Lp(a)] and cardiovascular disease (CVD); however, causal evidence, especially from the Chinese population, is lacking. Therefore, this study aims to estimate the causal association between variants in genes affecting Lp(a) concentrations and CVD in people of Han Chinese ethnicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two-sample Mendelian randomization analysis was used to assess the causal effect of Lp(a) concentrations on the risk of CVD. Summary statistics for Lp(a) variants were obtained from 1256 individuals in the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei. Data on associations between single-nucleotide polymorphisms (SNPs) and CVD were obtained from recently published genome-wide association studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen SNPs associated with Lp(a) levels in the Han Chinese population were used as instrumental variables. Genetically elevated Lp(a) was inversely associated with the risk of atrial fibrillation [odds ratio (OR), 0.94; 95% confidence interval (95%CI), 0.901\u20130.987; <jats:italic>P<\/jats:italic>\u2009=\u20090.012)], the risk of arrhythmia (OR, 0.96; 95%CI, 0.941\u20130.990; <jats:italic>P<\/jats:italic>\u2009=\u20090.005), the left ventricular mass index (OR, 0.97; 95%CI, 0.949\u20131.000; <jats:italic>P<\/jats:italic>\u2009=\u20090.048), and the left ventricular internal dimension in diastole (OR, 0.97; 95%CI, 0.950\u20130.997; <jats:italic>P<\/jats:italic>\u2009=\u20090.028) according to the inverse-variance weighted method. No significant association was observed for congestive heart failure (OR, 0.99; 95% CI, 0.950\u20131.038; <jats:italic>P<\/jats:italic>\u2009=\u20090.766), ischemic stroke (OR, 1.01; 95%CI, 0.981\u20131.046; <jats:italic>P<\/jats:italic>\u2009=\u20090.422), and left ventricular internal dimension in systole (OR, 0.98; 95%CI, 0.960\u20131.009; <jats:italic>P<\/jats:italic>\u2009=\u20090.214).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study provided evidence that genetically elevated Lp(a) was inversely associated with atrial fibrillation, arrhythmia, the left ventricular mass index and the left ventricular internal dimension in diastole, but not with congestive heart failure, ischemic stroke, and the left ventricular internal dimension in systole in the Han Chinese population. Further research is needed to identify the mechanism underlying these results and determine whether genetically elevated Lp(a) increases the risk of coronary heart disease or other CVD subtypes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01482-0","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T15:25:29Z","timestamp":1622561129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study"],"prefix":"10.1186","volume":"20","author":[{"given":"Juan","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"1482_CR1","first-page":"142","volume-title":"Annual report on cardiovascular health and diseases in China","author":"National Center for Cardiovascular Diseases, China","year":"2020","unstructured":"National Center for Cardiovascular Diseases, China. Annual report on cardiovascular health and diseases in China. Beijing: Science Press; 2020. p. 142\u2013222."},{"key":"1482_CR2","unstructured":"World Health Organization. https:\/\/www.who.int\/news\/item\/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019 (accessed January 19, 2021)."},{"issue":"4","key":"1482_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312. https:\/\/doi.org\/10.1038\/s41569-018-0119-4.","journal-title":"Nat Rev Cardiol"},{"issue":"05","key":"1482_CR4","first-page":"401","volume":"25","author":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of Report on Cardiovascular Health and Diseases in China","year":"2019","unstructured":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of Report on Cardiovascular Health and Diseases in China. Chin. J Cardiovasc Med, 2020. 2019;25(05):401\u201310.","journal-title":"J Cardiovasc Med, 2020"},{"key":"1482_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2018.06.863","volume":"275","author":"EM Ooi","year":"2018","unstructured":"Ooi EM, Ellis KL, Barrett PHR, Watts GF, Hung J, Beilby JP, et al. Lipoprotein(a) and apolipoprotein(a) isoform size: associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque. Atherosclerosis. 2018;275:232\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.863.","journal-title":"Atherosclerosis."},{"key":"1482_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2017.12.011","volume":"269","author":"LS Rallidis","year":"2018","unstructured":"Rallidis LS, Pavlakis G, Foscolou A, Kotakos C, Katsimardos A, Drosatos A, et al. High levels of lipoprotein (a) and premature acute coronary syndrome. Atherosclerosis. 2018;269:29\u201334. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.011.","journal-title":"Atherosclerosis."},{"issue":"27","key":"1482_CR7","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1093\/eurheartj\/ehy334","volume":"39","author":"R Verbeek","year":"2018","unstructured":"Verbeek R, Hoogeveen RM, Langsted A, Stiekema LCA, Verweij SL, Hovingh GK, et al. Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting. Eur Heart J. 2018;39(27):2589\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehy334.","journal-title":"Eur Heart J"},{"issue":"23","key":"1482_CR8","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehq386.","journal-title":"Eur Heart J"},{"issue":"1","key":"1482_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322. https:\/\/doi.org\/10.1093\/ije\/dyg070.","journal-title":"Int J Epidemiol"},{"issue":"5\u20136","key":"1482_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00508-010-1318-0","volume":"122","author":"J Boras","year":"2010","unstructured":"Boras J, Ljubic S, Car N, Metelko Z, Petrovecki M, Lovrencic MV, et al. Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: a four-year follow-up. Wien Klin Wochenschr. 2010;122(5\u20136):159\u201364. https:\/\/doi.org\/10.1007\/s00508-010-1318-0.","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"1482_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/ije\/dyq205","volume":"40","author":"M Kivim\u00e4ki","year":"2011","unstructured":"Kivim\u00e4ki M, Magnussen CG, Juonala M, K\u00e4h\u00f6nen M, Kettunen J, Loo BM, et al. Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the young Finns study. Int J Epidemiol. 2011;40(2):470\u20138. https:\/\/doi.org\/10.1093\/ije\/dyq205.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"1482_CR12","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1161\/STROKEAHA.119.026872","volume":"50","author":"Y Pan","year":"2019","unstructured":"Pan Y, Li H, Wang Y, Meng X, Wang Y. Causal effect of Lp(a) [lipoprotein(a)] level on ischemic stroke and Alzheimer disease: a Mendelian randomization study. Stroke. 2019;50(12):3532\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026872.","journal-title":"Stroke."},{"issue":"8","key":"1482_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jacc.2012.01.078","volume":"60","author":"A Helgadottir","year":"2012","unstructured":"Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol. 2012;60(8):722\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.01.078.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1482_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","volume":"67","author":"PR Kamstrup","year":"2021","unstructured":"Kamstrup PR. Lipoprotein(a) and cardiovascular disease. Clin Chem. 2021;67(1):154\u201366. https:\/\/doi.org\/10.1093\/clinchem\/hvaa247.","journal-title":"Clin Chem"},{"issue":"3","key":"1482_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.116.024611","volume":"135","author":"SR Lee","year":"2017","unstructured":"Lee SR, Prasad A, Choi YS, Xing C, Clopton P, Witztum JL, et al. LPA gene, ethnicity, and cardiovascular events. Circulation. 2017;135(3):251\u201363. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024611.","journal-title":"Circulation."},{"key":"1482_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cca.2018.06.004","volume":"484","author":"FM Cui","year":"2018","unstructured":"Cui FM, Fang F, He YM, Cai DP, He J, Yang XJ. Establishing age and sex dependent upper reference limits for the plasma lipoprotein (a) in a Chinese health check-up population and according to its relative risk of primary myocardial infarction. Clin Chim Acta. 2018;484:232\u20136. https:\/\/doi.org\/10.1016\/j.cca.2018.06.004.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1482_CR17","doi-asserted-by":"publisher","first-page":"e014581","DOI":"10.1161\/JAHA.119.014581","volume":"9","author":"HH Liu","year":"2020","unstructured":"Liu HH, Cao YX, Jin JL, Zhang HW, Hua Q, Li YF, et al. Predicting cardiovascular outcomes by baseline lipoprotein(a) concentrations: a large cohort and long-term follow-up study on real-world patients receiving percutaneous coronary intervention. J Am Heart Assoc. 2020;9(3):e014581. https:\/\/doi.org\/10.1161\/JAHA.119.014581.","journal-title":"J Am Heart Assoc"},{"key":"1482_CR18","doi-asserted-by":"publisher","first-page":"105981","DOI":"10.1016\/j.envint.2020.105981","volume":"143","author":"H Cao","year":"2020","unstructured":"Cao H, Li B, Peng W, Pan L, Cui Z, Zhao W, et al. Associations of long-term exposure to ambient air pollution with cardiac conduction abnormalities in Chinese adults: the CHCN-BTH cohort study. Environ Int. 2020;143:105981. https:\/\/doi.org\/10.1016\/j.envint.2020.105981.","journal-title":"Environ Int"},{"key":"1482_CR19","unstructured":"Cao H, Shan GL, Zhang L., An introduction of the cohort study on chronic diseases of natural population in the living community of Beijing-Tianjin-Hebei region. Chin J Evid Based Med, 2018. 18(6): p5."},{"key":"1482_CR20","doi-asserted-by":"publisher","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"issue":"7","key":"1482_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","volume":"52","author":"K Ishigaki","year":"2020","unstructured":"Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet. 2020;52(7):669\u201379. https:\/\/doi.org\/10.1038\/s41588-020-0640-3.","journal-title":"Nat Genet"},{"issue":"6","key":"1482_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/ng.3842","volume":"49","author":"SK Low","year":"2017","unstructured":"Low SK, Takahashi A, Ebana Y, Ozaki K, Christophersen IE, Ellinor PT, et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat Genet. 2017;49(6):953\u20138. https:\/\/doi.org\/10.1038\/ng.3842.","journal-title":"Nat Genet"},{"issue":"3","key":"1482_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","volume":"50","author":"M Kanai","year":"2018","unstructured":"Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390\u2013400. https:\/\/doi.org\/10.1038\/s41588-018-0047-6.","journal-title":"Nat Genet"},{"issue":"10","key":"1482_CR24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1161\/ATVBAHA.118.311220","volume":"38","author":"BT Steffen","year":"2018","unstructured":"Steffen BT, Duprez D, Bertoni AG, Guan W, Tsai MY. Lp(a) [lipoprotein(a)]-related risk of heart failure is evident in whites but not in other racial\/ethnic groups. Arterioscler Thromb Vasc Biol. 2018;38(10):2498\u2013504. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311220.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1482_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jchf.2015.08.006","volume":"4","author":"PR Kamstrup","year":"2016","unstructured":"Kamstrup PR, Nordestgaard BG. Elevated lipoprotein(a) levels, LPA risk genotypes, and increased risk of heart failure in the general population. JACC Heart Fail. 2016;4(1):78\u201387. https:\/\/doi.org\/10.1016\/j.jchf.2015.08.006.","journal-title":"JACC Heart Fail"},{"key":"1482_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2017.05.014","volume":"262","author":"A Agarwala","year":"2017","unstructured":"Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, et al. The association of lipoprotein(a) with incident heart failure hospitalization: atherosclerosis risk in communities study. Atherosclerosis. 2017;262:131\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.05.014.","journal-title":"Atherosclerosis."},{"issue":"24","key":"1482_CR27","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","volume":"74","author":"DF Gudbjartsson","year":"2019","unstructured":"Gudbjartsson DF, Thorgeirsson G, Sulem P, Helgadottir A, Gylfason A, Saemundsdottir J, et al. Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes. J Am Coll Cardiol. 2019;74(24):2982\u201394. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.019.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1482_CR28","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","volume":"139","author":"G Par\u00e9","year":"2019","unstructured":"Par\u00e9 G, \u00c7aku A, McQueen M, Anand SS, Enas E, Clarke R, et al. Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups. Circulation. 2019;139(12):1472\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034311.","journal-title":"Circulation."},{"issue":"2","key":"1482_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40119-020-00177-4","volume":"9","author":"K Pearson","year":"2020","unstructured":"Pearson K, Rodriguez F. Lipoprotein(a) and cardiovascular disease prevention across diverse populations. Cardiol Ther. 2020;9(2):275\u201392. https:\/\/doi.org\/10.1007\/s40119-020-00177-4.","journal-title":"Cardiol Ther"},{"issue":"1","key":"1482_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","volume":"74","author":"A Langsted","year":"2019","unstructured":"Langsted A, Nordestgaard BG, Kamstrup PR. Elevated lipoprotein(a) and risk of ischemic stroke. J Am Coll Cardiol. 2019;74(1):54\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.524.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1482_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.21037\/atm.2020.01.38","volume":"8","author":"H Fu","year":"2020","unstructured":"Fu H, Zhang D, Zhu R, Cui L, Qiu L, Lin S, et al. Association between lipoprotein(a) concentration and the risk of stroke in the Chinese Han population: a retrospective case-control study. Ann Transl Med. 2020;8(5):212. https:\/\/doi.org\/10.21037\/atm.2020.01.38.","journal-title":"Ann Transl Med"},{"key":"1482_CR32","doi-asserted-by":"crossref","unstructured":"Brandt EJ, Mani A, Spatz ES, Desai NR, Nasir K. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort. J Clin Lipidol. 2020; 14(5): 695\u2013706.e4.","DOI":"10.1016\/j.jacl.2020.06.010"},{"issue":"25","key":"1482_CR33","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.jacc.2016.10.033","volume":"68","author":"CA Emdin","year":"2016","unstructured":"Emdin CA, Khera AV, Natarajan P, Klarin D, Won HH, Peloso GM, et al. Phenotypic characterization of genetically lowered human lipoprotein(a) levels. J Am Coll Cardiol. 2016;68(25):2761\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.033.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1482_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412\u201323.","journal-title":"JAMA."},{"issue":"2","key":"1482_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","volume":"125","author":"SS Virani","year":"2012","unstructured":"Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the atherosclerosis risk in communities (ARIC) study. Circulation. 2012;125(2):241\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.045120.","journal-title":"Circulation."},{"issue":"4","key":"1482_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/ATVBAHA.118.311857","volume":"39","author":"P Arora","year":"2019","unstructured":"Arora P, Kalra R, Callas PW, Alexander KS, Zakai NA, Wadley V, et al. Lipoprotein(a) and risk of ischemic stroke in the REGARDS study. Arterioscler Thromb Vasc Biol. 2019;39(4):810\u20138. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311857.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1482_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","volume":"7","author":"S Mora","year":"2014","unstructured":"Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(4):612\u20139. https:\/\/doi.org\/10.1161\/CIRCEP.113.001378.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"1482_CR38","doi-asserted-by":"publisher","first-page":"e007372","DOI":"10.1161\/JAHA.117.007372","volume":"6","author":"KN Aronis","year":"2017","unstructured":"Aronis KN, Zhao D, Hoogeveen RC, Alonso A, Ballantyne CM, Guallar E, et al. Associations of lipoprotein(a) levels with incident atrial fibrillation and ischemic stroke: the ARIC (atherosclerosis risk in communities) study. J Am Heart Assoc. 2017;6(12):e007372.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"1482_CR39","doi-asserted-by":"publisher","first-page":"e008401","DOI":"10.1161\/CIRCEP.120.008401","volume":"13","author":"PK Garg","year":"2020","unstructured":"Garg PK, Guan W, Karger AB, Steffen BT, O'Neal W, Heckbert SR, et al. Lp(a) (lipoprotein [a]) and risk for incident atrial fibrillation: multi-ethnic study of atherosclerosis. Circ Arrhythm Electrophysiol. 2020;13(5):e008401. https:\/\/doi.org\/10.1161\/CIRCEP.120.008401.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1482_CR40","doi-asserted-by":"crossref","unstructured":"Guan B, Li X, Xue W, Tse G, Waleed KB, Liu Y, et al. Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020; 14(1): 133\u2013142.e3.","DOI":"10.1016\/j.jacl.2019.12.002"},{"issue":"1","key":"1482_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1523-1755.2004.00737.x","volume":"66","author":"F Kronenberg","year":"2004","unstructured":"Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, K\u00f6nig P, et al. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy? Kidney Int. 2004;66(1):348\u201354. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00737.x.","journal-title":"Kidney Int"},{"issue":"1","key":"1482_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5935\/abc.20140101","volume":"103","author":"RC Maranh\u00e3o","year":"2014","unstructured":"Maranh\u00e3o RC, Carvalho PO, Strunz CC, Pileggi F. Lipoprotein (a): structure, pathophysiology and clinical implications. Arq Bras Cardiol. 2014;103(1):76\u201384. https:\/\/doi.org\/10.5935\/abc.20140101.","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"1482_CR43","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-019-02082-8","volume":"14","author":"F Gragnano","year":"2019","unstructured":"Gragnano F, Fimiani F, Di Maio M, Cesaro A, Limongelli G, Cattano D, et al. Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease. Intern Emerg Med. 2019;14(4):621\u20135. https:\/\/doi.org\/10.1007\/s11739-019-02082-8.","journal-title":"Intern Emerg Med"},{"issue":"3","key":"1482_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2459\/JCM.0000000000001077","volume":"22","author":"A Cesaro","year":"2021","unstructured":"Cesaro A, Schiavo A, Moscarella E, Coletta S, Conte M, Gragnano F, et al. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies. J Cardiovasc Med (Hagerstown). 2021;22(3):151\u201361. https:\/\/doi.org\/10.2459\/JCM.0000000000001077.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"1482_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ije\/dyh132","volume":"33","author":"GD Smith","year":"2004","unstructured":"Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30\u201342. https:\/\/doi.org\/10.1093\/ije\/dyh132.","journal-title":"Int J Epidemiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T15:25:57Z","timestamp":1622561157000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01482-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHCN-BTH study was approved by the Ethics Committee of Center of Disease Control (IRB2017\u2013003, CYCDPCIRB-20170830-1) and Capital Medical University (2018SY81), and written informed consent was obtained from all individuals prior to the baseline survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}